TransEnterix, Inc. (NYSE: TRXC) today announced the Company has received FDA 510(k) clearance for the Senhance™ Surgical Robotic System.“The clearance ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News Management Comments

TransEnterix (TRXC) PT Raised to $4.50 at Ladenburg ThalmannOctober 17, 2017 11:10 AM TransEnterix (TRXC) Adds to Monday's Big GainsOctober 17, 2017 9:54 AM TransEnterix Announces US 510(k) FDA Clearance for Senhance Surgical Robotic SystemOctober 13, 2017 5:00 PM TransEnterix's (TRXC) Robotically-Assisted Surgical Device Cleared by FDAOctober 13, 2017 4:19 PM